Insights & Resources

Off-highway business use fuel tax claims are an often-overlooked opportunity. Learn more about how these state tax refunds can be used effectively.

New trends are shaping the food and beverage industry in 2025. Weaver’s strategies help companies navigate these changes for sustainable growth.

J.P. Morgan’s Q3 2024 Biopharma Report highlights robust venture investments, shifting licensing trends and a resurgence in IPO activity.

The U.S. Department of the Treasury and Internal Revenue Service have issued long-awaited guidance for the 45Z Clean Fuel Production Credit.

KPMG has released their 2024 biopharma report detailing the challenges and opportunities for pharma companies moving forward into the new year.

With 2024 coming to a close, time is running out for manufacturing companies to take advantage of many year-end tax benefits.

The medical technology, or medtech, industry is poised for a transformative year despite soft IPO activity the first half of 2024. Learn more here.

The biopharma industry has experienced a resurgence the first part of 2024. J.P. Morgan’s Q2 report shares critical insights into the future of the industry.

Unravel life sciences industry complexities, and discover the differences between FDA special review designations like Fast Track, Priority Review and Breakthrough.

The credit is aimed at bolstering and incentivizing the emerging biotechnology sector to create jobs and invest in NYC and is available 1/1/23-1/1/26.

Find out about energy-related tax credits for transportation and logistics companies that may take little or no changes to current operations.

Change Healthcare was impacted by a cybersecurity incident that breached its information technology network.